Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

1.

Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review.

Palazzolo DL.

Front Public Health. 2013 Nov 18;1:56. doi: 10.3389/fpubh.2013.00056. Review.

PMID:
24350225
[PubMed]
Free PMC Article
2.

Kinetic analysis of [11C]befloxatone in the human brain, a selective radioligand to image monoamine oxidase A.

Zanotti-Fregonara P, Leroy C, Roumenov D, Trichard C, Martinot JL, Bottlaender M.

EJNMMI Res. 2013 Nov 25;3(1):78. doi: 10.1186/2191-219X-3-78.

PMID:
24274579
[PubMed]
Free PMC Article
3.

How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways.

Moylan S, Jacka FN, Pasco JA, Berk M.

Brain Behav. 2013 May;3(3):302-26. doi: 10.1002/brb3.137. Epub 2013 Mar 26.

PMID:
23785661
[PubMed]
Free PMC Article
4.

Effects of smoking on D₂/D₃ striatal receptor availability in alcoholics and social drinkers.

Albrecht DS, Kareken DA, Yoder KK.

Brain Imaging Behav. 2013 Sep;7(3):326-34. doi: 10.1007/s11682-013-9233-4.

PMID:
23649848
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

PET radiopharmaceuticals for probing enzymes in the brain.

Holland JP, Cumming P, Vasdev N.

Am J Nucl Med Mol Imaging. 2013 Apr 9;3(3):194-216. Print 2013.

PMID:
23638333
[PubMed]
Free PMC Article
6.

Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies.

Tong J, Meyer JH, Furukawa Y, Boileau I, Chang LJ, Wilson AA, Houle S, Kish SJ.

J Cereb Blood Flow Metab. 2013 Jun;33(6):863-71. doi: 10.1038/jcbfm.2013.19. Epub 2013 Feb 13.

PMID:
23403377
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Potential contribution of aromatase inhibition to the effects of nicotine and related compounds on the brain.

Biegon A, Alia-Klein N, Fowler JS.

Front Pharmacol. 2012 Nov 6;3:185. doi: 10.3389/fphar.2012.00185. eCollection 2012.

PMID:
23133418
[PubMed]
Free PMC Article
8.

Impact of tobacco regulation on animal research: new perspectives and opportunities.

Donny EC, Taylor TG, LeSage MG, Levin M, Buffalari DM, Joel D, Sved AF.

Nicotine Tob Res. 2012 Nov;14(11):1319-38. doi: 10.1093/ntr/nts162. Epub 2012 Sep 4. Review.

PMID:
22949581
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Evidence that the methylation state of the monoamine oxidase A (MAOA) gene predicts brain activity of MAO A enzyme in healthy men.

Shumay E, Logan J, Volkow ND, Fowler JS.

Epigenetics. 2012 Oct;7(10):1151-60. doi: 10.4161/epi.21976. Epub 2012 Sep 4.

PMID:
22948232
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine.

Domino EF, Ni L, Domino JS, Yang W, Evans C, Guthrie S, Wang H, Koeppe RA, Zubieta JK.

Nicotine Tob Res. 2013 Jan;15(1):11-21. doi: 10.1093/ntr/nts029. Epub 2012 Apr 5.

PMID:
22491891
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Predicting nicotine dependence profiles among adolescent smokers: the roles of personal and social-environmental factors in a longitudinal framework.

Kleinjan M, Vitaro F, Wanner B, Brug J, Van den Eijnden RJ, Engels RC.

BMC Public Health. 2012 Mar 16;12:196. doi: 10.1186/1471-2458-12-196.

PMID:
22424115
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Tobacco addiction and the dysregulation of brain stress systems.

Bruijnzeel AW.

Neurosci Biobehav Rev. 2012 May;36(5):1418-41. doi: 10.1016/j.neubiorev.2012.02.015. Epub 2012 Mar 3. Review.

PMID:
22405889
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study.

Sacher J, Rabiner EA, Clark M, Rusjan P, Soliman A, Boskovic R, Kish SJ, Wilson AA, Houle S, Meyer JH.

J Cereb Blood Flow Metab. 2012 Mar;32(3):443-6. doi: 10.1038/jcbfm.2011.184. Epub 2011 Dec 21.

PMID:
22186668
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.

Bortolato M, Shih JC.

Int Rev Neurobiol. 2011;100:13-42. doi: 10.1016/B978-0-12-386467-3.00002-9. Review.

PMID:
21971001
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Quik M, Wonnacott S.

Pharmacol Rev. 2011 Dec;63(4):938-66. doi: 10.1124/pr.110.003269. Review.

PMID:
21969327
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Selegiline transdermal system (STS) as an aid for smoking cessation.

Kahn R, Gorgon L, Jones K, McSherry F, Glover ED, Anthenelli RM, Jackson T, Williams J, Murtaugh C, Montoya I, Yu E, Elkashef A.

Nicotine Tob Res. 2012 Mar;14(3):377-82. doi: 10.1093/ntr/ntr143. Epub 2011 Aug 16.

PMID:
21846661
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder.

Johnson S, Stockmeier CA, Meyer JH, Austin MC, Albert PR, Wang J, May WL, Rajkowska G, Overholser JC, Jurjus G, Dieter L, Johnson C, Sittman DB, Ou XM.

Neuropsychopharmacology. 2011 Sep;36(10):2139-48. doi: 10.1038/npp.2011.105. Epub 2011 Jun 8.

PMID:
21654740
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Gene environment interactions with a novel variable Monoamine Oxidase A transcriptional enhancer are associated with antisocial personality disorder.

Philibert RA, Wernett P, Plume J, Packer H, Brody GH, Beach SR.

Biol Psychol. 2011 Jul;87(3):366-71. doi: 10.1016/j.biopsycho.2011.04.007. Epub 2011 May 7.

PMID:
21554924
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.

Sacher J, Houle S, Parkes J, Rusjan P, Sagrati S, Wilson AA, Meyer JH.

J Psychiatry Neurosci. 2011 Nov;36(6):375-82. doi: 10.1503/jpn.100117.

PMID:
21463543
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition.

Lotfipour S, Arnold MM, Hogenkamp DJ, Gee KW, Belluzzi JD, Leslie FM.

Neuropharmacology. 2011 Jul-Aug;61(1-2):95-104. doi: 10.1016/j.neuropharm.2011.03.007. Epub 2011 Mar 23.

PMID:
21419142
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk